Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

iBio, Inc.

IBIONASDAQ
Healthcare
Biotechnology
$2.39
$-0.06(-2.45%)
U.S. Market opens in 15h 55m

iBio, Inc. (IBIO) Stock Overview

Explore iBio, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap37.7M
P/E Ratio-9.66
EPS (TTM)$-1.00
ROE-0.71%
Fundamental Analysis

AI Price Forecasts

1 Month$-0.61
3 Months$0.06
1 Year Target$0.00

IBIO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of iBio, Inc. (IBIO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.22, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -9.66 and a market capitalization of 37.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.45%
5-Day Change
0.42%
1-Month Change
4.37%
3-Month Change
16.02%
6-Month Change
176.52%
Year-to-Date (YTD) Change
18.32%
1-Year Change
-50.82%
3-Year Change
-94.11%
5-Year Change
-99.73%
All-Time (Max) Change
-99.95%

Contact Information

979 446 0027
8800 HSC Parkway, Bryan, TX, 77807

Company Facts

160 Employees
IPO DateAug 19, 2008
CountryUS
Actively Trading

Frequently Asked Questions